To identify the prognostic variables relative to myopic choroidal neovascularization (CNV) treated with intravitreal ranibizumab/bevacizumab.
FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION / Iacono, P., Battaglia Parodi, M., Selvi, F., Parravano, M.C., Chiaravalloti, A., Varano, M., Bandello, F.. - In: RETINA. - ISSN 0275-004X. - 37:10(2017), pp. 1931-1941-1941. [10.1097/IAE.0000000000001436]
FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION
Battaglia Parodi, Maurizio;Bandello, Francesco
2017-01-01
Abstract
To identify the prognostic variables relative to myopic choroidal neovascularization (CNV) treated with intravitreal ranibizumab/bevacizumab.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


